These findings are an important step forward in understanding the pathophysiology of NASH and the contribution and interaction of Elovl6 in hepatic inflammation associated with hepatic lipid accumulation. The gene discussed is ELOVL6; the disease is metabolic dysfunction-associated steatohepatitis.